Breast Surgery Collaborative Community Proposes Streamlined FDA Breast Implant Patient Decision Checklist
The Breast Surgery Collaborative Community (BSCC), a group comprising patient advocates and board-certified plastic surgeons, has submitted a proposed update to the U.S. Food and Drug Administration's (FDA) Breast Implant Patient Decision Checklist. This revised checklist aims to shorten and clarify the existing document to better facilitate shared decision-making between patients and surgeons. Since its implementation in 2022, concerns have been raised by both patients and clinicians regarding the checklist's length, clarity, and practical utility as an educational tool. Patient advocates have specifically called for a more concise document that would complement, rather than complicate, existing informed consent processes for breast implant procedures. The BSCC's revision effort involved patients, surgeons, and manufacturers, with the goal of making the checklist more patient-friendly, understandable, and practical for real-world clinical use. The BSCC is encouraging public input on the proposal, with com...
